Most people who wear hearing aids think of them as something they put in each morning and take out at night. That routine works well for the majority of patients — but it also means that for a significant portion of the day and night, the device isn’t in. The moments hearing aids are most commonly absent aren’t just inconvenient. They’re in the middle of the night when the phone rings, during a morning shower when someone calls through the door, or during sleep, when awareness of the environment — a smoke alarm, a child — genuinely matters. For many users, there’s also the quiet but persistent reminder of removing a visible device each evening. Phonak Lyric was designed to eliminate all of that.
What Makes Lyric Different
Lyric is the world’s only extended-wear hearing device. It is placed deep in the ear canal — within approximately 4 millimeters of the eardrum — by a trained hearing care professional, and it remains there continuously for up to three to four months. The wearer does not remove it at night. They shower with it in. They sleep with it in. They don’t touch it, charge it, or interact with it in any way until it’s time for a replacement fitting.
This is not a standard hearing aid placed deeper than usual. Lyric is specifically engineered for extended continuous wear: its biocompatible foam seal conforms to each ear canal’s unique geometry, its components are designed to tolerate the humidity and temperature of the ear canal environment over months of continuous use, and its acoustic placement near the eardrum allows it to leverage the natural amplification properties of the outer ear — the pinna and the ear canal resonance — in ways that devices sitting at the canal entrance cannot fully replicate.
What the Evidence Shows
Because Lyric sits deep in the canal, it benefits from the same resonance effects that support natural sound localization. This contributes to what many users describe as a more transparent, natural sound quality — less like wearing a device, more like the hearing they remember.
Phonak’s field studies support this perception. In a field study of the Lyric3.1 model (Phonak, 2015), 86% of wearers rated sound quality as very natural, and 93% said they would recommend the device to others — satisfaction rates that exceed most conventional hearing aid benchmarks. A clinical and medical review published by Phonak in 2019 documented the safety profile across extended-wear users, finding that continuous 24/7 wear was well-tolerated by appropriate candidates, with no increase in serious adverse events compared to traditional devices. A comparative pilot study included in that review found that self-replacement procedures — available for experienced Lyric users — were as safe and effective as audiologist-performed replacements, with minimal variability in outcomes (Phonak Clinical Insight, 2019).
For professionals, Lyric also offers a substantive conversation with patients who are resistant to visible devices or who have tried conventional aids and found the maintenance burden — batteries, charging, daily insertion and removal — to be a barrier to consistent use. Consistent use is, after all, the variable that determines outcomes more than almost any device specification.
Who Is a Candidate?
Lyric candidacy evaluation is a detailed, individualized process — and not everyone qualifies. The device is contraindicated for patients with recurrent outer ear infections, active ear canal disease, significant anatomical variations, or structural features that prevent proper fit. It is designed for patients with mild to moderately severe sensorineural hearing loss, and is not currently approved for patients with significant low-frequency hearing loss patterns.
Lyric is dispensed as a subscription service rather than a single purchase. The annual subscription provides continuous device replacements throughout the year. For patients who do qualify, this model eliminates the depreciation concern associated with conventional hearing aids, though the total annual cost is comparable to — or in some cases exceeds — conventional device pricing depending on technology tier.
One nuance worth flagging: because Lyric cannot be easily self-removed, patients who have significant anxiety around having a device inside the ear canal should be counseled carefully before proceeding. A properly fit Lyric should be undetectable to the wearer; one that isn’t seated correctly can cause a sense of occlusion, autophony, or discomfort. Comfort on day one is a good predictor of long-term satisfaction.
The Bigger Picture
Lyric’s appeal isn’t primarily about invisibility, though that matters to many patients. It’s about frictionless access to better hearing — no maintenance routine, no daily insertion, no dead batteries at inconvenient moments, no gaps in use during the hours when it might matter most. For the right candidate, it delivers on that promise reliably. For the broader population of hearing aid candidates, it represents something equally valuable: evidence that the future of hearing care may look quite different from the technologies we take for granted today.
If you’re curious about extended-wear options, a consultation with an audiologist experienced in Lyric candidacy evaluation is the right starting point. The fit and candidacy process is specific enough that general information only goes so far.
References
- Phonak. (2019). Lyric Clinical and Medical Review. Phonak Clinical Insight, June 2019.
- Phonak. (2015). Speech clarity, naturalness of sound, and overall acceptance of Lyric3.1. Phonak Field Study News, October 2015.
- Biggins, A., Singh, G., & Solodar, H. (2017). Extended wear hearing aid field study on psychosocial benefits. Phonak Field Study News.